ACOSOG Z0011 Trial: 10-Year Survival Results Reported
ACOSOG Z0011 Trial: 10-Year Survival Results Reported
Data Indicates Practice Changes at Institutions
The 10-year survival results of the American College of Surgeons Oncology Group ACOSOG Z0011 trial have been reported, providing valuable insights for the treatment of women with breast cancer.
The Z0011 trial compared observation to axillary dissection in women with a positive sentinel lymph node (SLN) and clinical T1-T2 tumors. The results showed that observation was safe and effective as axillary dissection, with similar long-term survival rates.
The current study suggests that the Z0011 data has resulted in practice changes at institutions. Many institutions have adopted observation as the standard of care for women meeting the trial's criteria, reducing the need for unnecessary axillary dissection and its potential complications.
The Z0011 trial has made a significant contribution to the understanding of the role of axillary dissection in breast cancer treatment. Its findings have helped to optimize care for women with breast cancer by providing evidence-based guidance on the use of axillary dissection.
Comments